Dr. Prutchi-Sagiv serves as the VP R&D of Gynica a medical company researching and developing cannabinoid solutions to target gynaecological symptoms and diseases.
She has over 15 years of experience in various aspects of pharmaceutical development including preclinical and clinical studies, regulatory affairs and IP. Over the last 10 years, Dr. Prutchi-Sagiv has lead scientific operations in multiple cannabis-based drug companies including Kalytera, Talent Biotechs, Stero Biotechs and BOL Pharma. At Gynica, she is responsible for the development of cannabis-based solutions in the women’s health field. She also serves as Director of Tech Transfer at Mor Research Applications (Clalit Health Services commercializing arm), where she is responsible for the pharma and diagnostics department.